Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT07379424 is registered in ClinicalTrials.gov with chen chao Professor as lead sponsor.

NCT NCT07379424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07379424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Lead sponsor
chen chao Professor
Phase
Phase 2
Overall status
Not yet recruiting
Start date
January 28, 2026
Completion date
August 25, 2028
Enrollment
37 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

resectable locally advanced head and neck squamous cell carcinoma